SCHEMBL6510356

SCHEMBL6510356

Cc1ccccc1ONc1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 1/20 0.46
SMN1; SMN2 Q16637 4/20 0.41
CYP1A2 P05177 4/20 0.41
CYP3A4 P08684 4/20 0.41
HTT P42858 1/20 0.41
POLB P06746 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
TSHR P16473 5/20 0.41
KMT2A Q03164 3/20 0.41
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
MEN1 O00255 2/20 0.41
DRD2 P14416 1/20 0.39
DRD4 P21917 1/20 0.39
SCN4A P35499 1/20 0.38
MITF O75030 1/20 0.38
NFKB1 P19838 1/20 0.38
NFKB2 Q00653 1/20 0.38
RELA Q04206 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3460086 0.84 ALDH1A1 (0.43) NOTUMSMN1; SMN2CYP1A2CYP3A4HTT
SCHEMBL28383789 0.83 TDP1 (0.44) NOTUMSMN1; SMN2CYP1A2CYP3A4HTT
SCHEMBL23326387 0.80 MEN1 (0.43) SMN1; SMN2HTTKMT2ANPC1RAB9A
SCHEMBL28386387 0.79 GAA (0.40) NOTUMSMN1; SMN2CYP1A2CYP2C19KMT2A
SCHEMBL30910832 0.77 TSHR (0.52) NOTUMSMN1; SMN2CYP1A2CYP3A4TSHR
SCHEMBL12850729 0.75 TSHR (0.45) NOTUMSMN1; SMN2CYP1A2CYP3A4TSHR
SCHEMBL11332939 0.74 TDP1 (0.35) CYP1A2CYP3A4CYP2C9CYP2C19TSHR
SCHEMBL9417471 0.74 SMN1; SMN2 (0.41) NOTUMSMN1; SMN2HTTPOLBTSHR
SCHEMBL3066977 0.72 NOTUM (0.49) NOTUMSMN1; SMN2HTTPOLBTSHR
SCHEMBL944403 0.71 LMNA (0.49) SMN1; SMN2TSHRKMT2AMEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102388037-B Quinazolinones as prolyl hydroxylase inhibitors JANSSEN PHARMACEUTICA NV 2014-12-03 CN disclosed
CN-102388037-A Quinazolinones as prolyl hydroxylase inhibitors JANSSEN PHARMACEUTICA NV 2012-03-21 CN disclosed
WO-2005037839-A1 NORCANTHARIDIN DERIVATIVE COMPOUNDS, METHOD FOR THE PRODUCTION THEREOF, COMPOSITIONS CONTAINING SAID COMPOUNDS AND THE USE THEREOF ENTOMED (FR) 2005-04-28 WO disclosed
EP-0261837-B1 Process for the preparation of electrically conductive material SANYO ELECTRIC CO (JP) 2001-07-11 EP disclosed
EP-0646837-B1 Clad vanadium pentoxide materials, conductive layers and photographic elements containing the same EASTMAN KODAK CO (US) 1999-08-04 EP disclosed
US-5654089-A IMAGING ELEMENTS EASTMAN KODAK COMPANY (US) 1997-08-05 US disclosed
US-5455153-A Cladding is a oxidatively polymerizable polymer EASTMAN KODAK COMPANY (US) 1995-10-03 US disclosed
EP-0646837-A1 Clad vanadium pentoxide materials, conductive layers and photographic elements containing the same EASTMAN KODAK COMPANY (US) 1995-04-05 EP disclosed
US-4795687-A POLYTHIENYLENE, POLYPRYRROLE OR POLYANILINE MATERIAL PREPARED BY OXIDATION POLYMERIZATION MITSUBISHI KASEI CORP. (JP) 1989-01-03 US disclosed